Paget's Disease of Bone

Ethel S. Siris, G. David Roodman

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

This chapter discusses the etiology, pathology, clinical features, diagnosis, and treatment of Paget's disease. Although Paget's disease is the second most common bone disease after osteoporosis, the factors involved in its pathogenesis are just beginning to be clarified. Both genetic and environmental factors have been implicated in the pathophysiology of Paget's disease. The initiating lesion in Paget's disease is an increase in bone resorption due to an abnormality in the osteoclasts found at affected sites. Measurements of biochemical markers of bone turnover are useful clinically in the assessment of the extent and severity of disease in the untreated state and for monitoring the response to treatment. Specific antipagetic therapy consists of those agents capable of suppressing the activity of pagetic osteoclasts. Other symptomatic treatments for Paget's disease, including analgesics, anti-inflammatory drugs, use of orthotics or canes, and selected orthopedic and neurosurgical interventions, have important roles in management in many patients.

Original languageEnglish (US)
Title of host publicationPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition
PublisherWiley Blackwell
Pages659-668
Number of pages10
ISBN (Electronic)9781118453926
ISBN (Print)9781118453889
DOIs
StatePublished - Jul 19 2013

Fingerprint

Osteitis Deformans
Bone
Osteoclasts
Orthotics
Canes
Clinical Pathology
Bone Remodeling
Bone Diseases
Non-Steroidal Anti-Inflammatory Agents
Therapeutics
Bone Resorption
Orthopedics
Pathology
Osteoporosis
Biomarkers
Monitoring
Pharmaceutical Preparations

Keywords

  • Antipagetic therapy
  • Bone remodeling
  • Osteoporosis
  • Paget's disease

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Siris, E. S., & Roodman, G. D. (2013). Paget's Disease of Bone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition (pp. 659-668). Wiley Blackwell. https://doi.org/10.1002/9781118453926.ch80

Paget's Disease of Bone. / Siris, Ethel S.; Roodman, G. David.

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, 2013. p. 659-668.

Research output: Chapter in Book/Report/Conference proceedingChapter

Siris, ES & Roodman, GD 2013, Paget's Disease of Bone. in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, pp. 659-668. https://doi.org/10.1002/9781118453926.ch80
Siris ES, Roodman GD. Paget's Disease of Bone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell. 2013. p. 659-668 https://doi.org/10.1002/9781118453926.ch80
Siris, Ethel S. ; Roodman, G. David. / Paget's Disease of Bone. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. Wiley Blackwell, 2013. pp. 659-668
@inbook{8f394953d6ba4eb7b9d4512e0cb42fed,
title = "Paget's Disease of Bone",
abstract = "This chapter discusses the etiology, pathology, clinical features, diagnosis, and treatment of Paget's disease. Although Paget's disease is the second most common bone disease after osteoporosis, the factors involved in its pathogenesis are just beginning to be clarified. Both genetic and environmental factors have been implicated in the pathophysiology of Paget's disease. The initiating lesion in Paget's disease is an increase in bone resorption due to an abnormality in the osteoclasts found at affected sites. Measurements of biochemical markers of bone turnover are useful clinically in the assessment of the extent and severity of disease in the untreated state and for monitoring the response to treatment. Specific antipagetic therapy consists of those agents capable of suppressing the activity of pagetic osteoclasts. Other symptomatic treatments for Paget's disease, including analgesics, anti-inflammatory drugs, use of orthotics or canes, and selected orthopedic and neurosurgical interventions, have important roles in management in many patients.",
keywords = "Antipagetic therapy, Bone remodeling, Osteoporosis, Paget's disease",
author = "Siris, {Ethel S.} and Roodman, {G. David}",
year = "2013",
month = "7",
day = "19",
doi = "10.1002/9781118453926.ch80",
language = "English (US)",
isbn = "9781118453889",
pages = "659--668",
booktitle = "Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Paget's Disease of Bone

AU - Siris, Ethel S.

AU - Roodman, G. David

PY - 2013/7/19

Y1 - 2013/7/19

N2 - This chapter discusses the etiology, pathology, clinical features, diagnosis, and treatment of Paget's disease. Although Paget's disease is the second most common bone disease after osteoporosis, the factors involved in its pathogenesis are just beginning to be clarified. Both genetic and environmental factors have been implicated in the pathophysiology of Paget's disease. The initiating lesion in Paget's disease is an increase in bone resorption due to an abnormality in the osteoclasts found at affected sites. Measurements of biochemical markers of bone turnover are useful clinically in the assessment of the extent and severity of disease in the untreated state and for monitoring the response to treatment. Specific antipagetic therapy consists of those agents capable of suppressing the activity of pagetic osteoclasts. Other symptomatic treatments for Paget's disease, including analgesics, anti-inflammatory drugs, use of orthotics or canes, and selected orthopedic and neurosurgical interventions, have important roles in management in many patients.

AB - This chapter discusses the etiology, pathology, clinical features, diagnosis, and treatment of Paget's disease. Although Paget's disease is the second most common bone disease after osteoporosis, the factors involved in its pathogenesis are just beginning to be clarified. Both genetic and environmental factors have been implicated in the pathophysiology of Paget's disease. The initiating lesion in Paget's disease is an increase in bone resorption due to an abnormality in the osteoclasts found at affected sites. Measurements of biochemical markers of bone turnover are useful clinically in the assessment of the extent and severity of disease in the untreated state and for monitoring the response to treatment. Specific antipagetic therapy consists of those agents capable of suppressing the activity of pagetic osteoclasts. Other symptomatic treatments for Paget's disease, including analgesics, anti-inflammatory drugs, use of orthotics or canes, and selected orthopedic and neurosurgical interventions, have important roles in management in many patients.

KW - Antipagetic therapy

KW - Bone remodeling

KW - Osteoporosis

KW - Paget's disease

UR - http://www.scopus.com/inward/record.url?scp=84945570230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945570230&partnerID=8YFLogxK

U2 - 10.1002/9781118453926.ch80

DO - 10.1002/9781118453926.ch80

M3 - Chapter

AN - SCOPUS:84945570230

SN - 9781118453889

SP - 659

EP - 668

BT - Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

PB - Wiley Blackwell

ER -